Pharmaceutical

Ardelyx sues CMS over revamped kidney disease drug payment bundle

Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and CMS’ revamped kidney disease payment scheme.

Jul 20, 2024 - 04:00
Ardelyx sues CMS over revamped kidney disease drug payment bundle
Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and CMS’ revamped kidney disease payment scheme.
Read the original article

Tags:

Previous Article

EMA accepts Deciphera’s MAA cell tumour treatment for review

Next Article

FDA launches new rare disease innovation hub

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Midland Pharmaceuticals launches to advance spinal injury therapeutics

Midland Pharmaceuticals launches to advance spinal inju...

Jun 2, 2024

STAT+: With Apollo Endosurgery acquisition, Boston Scientific dives into the obesity treatment market

STAT+: With Apollo Endosurgery acquisition, Boston Scie...

Apr 7, 2023

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Interview: Dr Alan S Louie – US Food and Drug Administr...

Apr 16, 2023